Literature DB >> 28549294

Chiral recognition of naproxen enantiomers based on fluorescence quenching of bovine serum albumin-stabilized gold nanoclusters.

Marzieh Jafari1, Javad Tashkhourian2, Ghodratollah Absalan3.   

Abstract

A simple, fast and green method for chiral recognition of S- and R-naproxen has been introduced. The method was based on quenching of the fluorescence intensity of bovine serum albumin-stabilized gold nanoclusters in the presence of naproxen enantiomers. The quenching intensity in the presence of S-naproxen was higher than R-naproxen when phosphate buffer solution at pH7.0 was used. The chiral recognition occurred due to steric effect between bovine serum albumin conformation and naproxen enantiomers. Two linear determination range were established as 7.4×10-7-9.1×10-6 and 9.1×10-6-3.1×10-5molL-1 for both enantiomers and detection limits of 7.4×10-8molL-1 and 9.5×10-8molL-1 were obtained for S- and R-naproxen, respectively. The developed method showed good repeatability and reproducibility for the analysis of a synthetic sample. To make the procedure applicable to biological samples, the removal of heavy metals from the sample is suggested before any analytical attempt.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bovine serum albumin; Chiral recognition; Fluorescence determination; Gold nanoclusters; Naproxen enantiomers

Mesh:

Substances:

Year:  2017        PMID: 28549294     DOI: 10.1016/j.saa.2017.05.029

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  2 in total

1.  Protamine-stabilized gold nanoclusters as a fluorescent nanoprobe for lead(II) via Pb(II)-Au(I) interaction.

Authors:  Yan-Qin Huang; Li-Na Yang; Yong-Sheng Wang; Jin-Hua Xue; Si-Han Chen
Journal:  Mikrochim Acta       Date:  2018-09-29       Impact factor: 5.833

2.  Luminescent metal clusters/barium sulfate composites for white light-emitting devices and anti-counterfeiting labels.

Authors:  Min Wang; Zhenzhen Huang; Zilong Guo; Wensheng Yang
Journal:  RSC Adv       Date:  2018-01-15       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.